We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Genomic Endometrial Expression in Obesity

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00505986
Recruitment Status : Completed
First Posted : July 25, 2007
Last Update Posted : April 2, 2012
Information provided by (Responsible Party):
Jose Bellver, Instituto Valenciano de Infertilidad, Spain

Brief Summary:
Determine if different genomic endometrial expression exists during embryo implantation in obese women in comparison with non obese women.

Condition or disease Intervention/treatment
Obesity and Embryo Implantation Procedure: endometrial biopsy

Study Type : Interventional  (Clinical Trial)
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Study Start Date : June 2007
Primary Completion Date : May 2009
Study Completion Date : May 2009

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 35 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • group A: non obese oocyte donors (BMI: 18 - 29 kg. /m2)with proven fertility
  • group B: obese oocyte donors: (BMI: >29 kg./m2)with proven fertility
  • group C: obese (BMI: >29 kg./m2) infertile patients,

Exclusion Criteria:

  • recurrent miscarriage

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00505986

Instituto Valenciano de Infertilidad Spain
Valencia, Spain, 46015
Sponsors and Collaborators
Instituto Valenciano de Infertilidad, IVI VALENCIA
Principal Investigator: Jose Bellver, MD PhD Instituto Valenciano de Infertilidad

Responsible Party: Jose Bellver, Gynecologist IVI Valencia, Instituto Valenciano de Infertilidad, Spain
ClinicalTrials.gov Identifier: NCT00505986     History of Changes
Other Study ID Numbers: VLC-JB-0507-607-29
First Posted: July 25, 2007    Key Record Dates
Last Update Posted: April 2, 2012
Last Verified: March 2012

Additional relevant MeSH terms:
Nutrition Disorders
Body Weight
Signs and Symptoms